Total raised
—
Stage
Pre-Funding
Founded
2016
Headcount
1-10
HQ
Bet Shemesh
Sector
Health Tech & Life Sciences
About
CardioLync provides a platform for interpreting cardiovascular studies, reporting, and patient management of their cardiac history. With CardioLync's technology and easy-to-use interface, clinical data is moved seamlessly and securely so that clinicians can read and interpret diagnostic studies at their convenience and patients can access their imaging history anywhere.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is the current operational status of CardioLync?
- CardioLync is currently inactive and ceased to operate in November 2022.
- When was CardioLync founded and where is its headquarters located?
- CardioLync was founded in January 2016 and is headquartered in Bet Shemesh, Israel.
- What is CardioLync's primary product or offering?
- CardioLync offers a product called Diagnostic Modality Interface Portal (DMIP), which is a platform for interpreting cardiovascular studies, reporting, and patient management.
- Which program did CardioLync join in August 2021?
- In August 2021, CardioLync joined NVIDIA Inception.
- Who are the co-founders of CardioLync?
- The co-founders of CardioLync are Jeremy Kagan and Jacob Levy, MD FACC.
- What was a notable event for CardioLync in December 2021?
- In December 2021, Professor David Leibowitz, MD FACC, joined CardioLync's Scientific Advisory Board.
- What was a significant event for CardioLync in February 2022?
- In February 2022, Dr. Diego Gicovate, PhD, joined CardioLync's Scientific Advisory Board.
- In which geographic markets did CardioLync operate?
- CardioLync operated in the United States and Europe.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareClinical WorkflowPatient Engagement
Technologies
Platforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesHealthcareProvidersPatientsLife SciencesPharmaceuticals
Business model
B2B2CB2B
Highlights
Verified
Tags
diagnosticsclinical-workflowmedical-dataschedulinghealthcare-providersimagingdigital-therapeuticscardiologysurgerynon-invasivedigital-healthcareweb-platformsoftware-applicationsdata-analyticsradiologycardiovascularmhealthcross-platformheart-diseasesmonitoringmedical-technologiestreatmentspatientspharma-companiestelehealthtelematicstelemedicinehospitalsdoctors